CLINICAL_TRIALS
trial_result
· 2016-05-11
Clinical Trial Update: Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1) [Phase 2]
Summary
Phase 2 clinical trial of Plovamer Acetate for relapsing-remitting multiple sclerosis was terminated; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2016-05-11